News

A recent study led by Andrew Sauer, M.D., cardiologist at Saint Luke’s Mid America Heart Institute, showed that for patients with heart failure, hospital participation in the IMPLEMENT-HF initiative improves patient care.

To combat rising maternal mortality, researchers at Saint Luke's Mid America Heart Institute and UMKC are leading a first of its kind study to create better care for moms with heart conditions during pregnancy.

After a fainting spell, Angela Alvarez was ultimately diagnosed with cardiomyopathy and congestive heart failure. Her original plan of action was to undergo a heart transplant, but she sought a second opinion at Saint Luke’s Mid America Heart Institute.

This MS awareness month, Dr. Carolina Garcia, a neurologist at Saint Luke's Comprehensive Multiple Sclerosis Center, discusses diagnosing and treating this inflammatory and presumed autoimmune condition.

Kansas City is poised to become a national leader in addressing the nation’s maternal health crisis, and there’s a way for you to help or to be treated if you’re pregnant and have a heart condition.

Heart disease remains the number one health threat for women, causing 1 in 3 deaths each year—that's more than all forms of cancer combined.

A local man with heart failure who was told numerous times he only had months to live gets a second chance at life after treatment at Saint Luke's.

When Debbie O’Neal was diagnosed with heart failure at 75, she feared her life was ending. She was the same age that her mother had been when she died of heart disease.

Growing research shows why popular GLP-1 weight loss medications might be beneficial for people with multiple sclerosis, but the jury’s still out.

Empower yourself by learning all you can about therapies for multiple sclerosis.